Nov 17, 2023
STRIDE validated in human in-vivo samples in collaboration with AstraZeneca
In collaboration with AstraZeneca, intoDNA has validated STRIDE as a groundbreaking tool for quantification of DNA breaks in different types of human clinical samples.
Nov 17, 2023
STRIDE validated in human in-vivo samples in collaboration with AstraZeneca
Nov 03, 2023
intoDNA exhibits at SITC 2023, the premier cancer immunotherapy conference
Jul 11, 2023
intoDNA to participate in the 2nd Annual Targeted Radiopharmaceuticals Summit US (TRP)
Mar 28, 2023
intoDNA to present and exhibit at the American Association for Cancer Research Annual Meeting 2023
Jul 19, 2022
intoDNA joins the BioInMed initiative gathering key medical biotechnology companies in Poland
Apr 28, 2022
Magda Kordon as an invited speaker at the DNA Repair/Replication Structures & Cancer Conference
Feb 24, 2022
Magda Kordon, CEO attending the 2022 Gordon Research Conference on DNA Damage, Mutation and Cancer
Sep 28, 2021